エピソード

  • Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma

    Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma
    2024/10/24

    Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD.

    Related Content:

    • Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma
    続きを読む 一部表示
    21 分
  • Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer

    Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer
    2024/09/05

    Interview with Eileen M. O’Reilly, MD, author of Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer. Hosted by Vivek Subbiah, MD.

    Related Content:

    • Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer
    続きを読む 一部表示
    17 分
  • Identification of Immune Checkpoint Inhibitor–Induced Diabetes

    Identification of Immune Checkpoint Inhibitor–Induced Diabetes
    2024/08/29

    Interview with Michelle Rengarajan, MD, PhD, author of Identification of Immune Checkpoint Inhibitor–Induced Diabetes. Hosted by Vivek Subbiah, MD.

    Related Content:

    • Identification of Immune Checkpoint Inhibitor–Induced Diabetes
    続きを読む 一部表示
    15 分
  • Neoadjuvant Exercise Therapy in Prostate Cancer

    Neoadjuvant Exercise Therapy in Prostate Cancer
    2024/07/18

    Interview with Lee W. Jones, PhD, author of Neoadjuvant Exercise Therapy in Prostate Cancer: A Phase 1, Decentralized Nonrandomized Controlled Trial. Hosted by Vivek Subbiah, MD.

    Related Content:

    • Neoadjuvant Exercise Therapy in Prostate Cancer
    続きを読む 一部表示
    19 分
  • Endometrial Thickness as Diagnostic Triage for Endometrial Cancer in Black Individuals

    Endometrial Thickness as Diagnostic Triage for Endometrial Cancer in Black Individuals
    2024/06/27

    Interview with Kemi M. Doll, MD, MSCR, author of Endometrial Thickness as Diagnostic Triage for Endometrial Cancer Among Black Individuals. Hosted by Vivek Subbiah, MD.

    Related Content:

    • Endometrial Thickness as Diagnostic Triage for Endometrial Cancer Among Black Individuals
    続きを読む 一部表示
    15 分
  • T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy

    T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy
    2024/04/18

    Interview with Roni Shouval, MD, PhD, author of T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy. Hosted by Vivek Subbiah, MD.

    Related Content:

    • T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy
    続きを読む 一部表示
    20 分
  • Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time

    Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time
    2024/03/21

    Interview with Tobias Janowitz, MD, PhD, and Karen Winkfield, MD, PhD, authors of Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time. Hosted by Vivek Subbiah, MD.

    Related Content:

    • Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time
    続きを読む 一部表示
    26 分
  • Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer

    Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer
    2024/02/29

    Interview with José P. Leone, MD, author of Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer. Hosted by Nora L. (Mary) Disis, MD.

    Related Content:

    • Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer
    続きを読む 一部表示
    14 分